Harrow, Inc. (HROW): Net Income
-$5.14M
Year ended 2025-12-31
-$37.23M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$5.14M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | -$17.48M | n/m | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | -$24.41M | n/m | 2026-03-02, From 2023-01-01 |
| 2022-12-31 | -$14.09M | n/m | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | -$18.01M | n/m | 2023-03-23, From 2021-01-01 |
| 2020-12-31 | -$3.36M | n/m | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $168.0K | -98.9% | 2021-03-08, From 2019-01-01 |
| 2018-12-31 | $14.62M | n/m | 2020-03-13, From 2018-01-01 |
| 2017-12-31 | -$11.98M | n/m | 2019-03-12, From 2017-01-01 |
| 2016-12-31 | -$19.09M | n/m | 2018-03-08, From 2016-01-01 |
| 2015-12-31 | -$15.90M | n/m | 2017-03-21, From 2015-01-01 |
| 2014-12-31 | -$10.12M | n/m | 2016-03-23, From 2014-01-01 |
| 2013-12-31 | -$7.64M | n/m | 2015-03-12, From 2013-01-01 |
| 2012-12-31 | -$5.38M | n/m | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | -$953.9K | n/m | 2014-03-28, From 2011-01-01 |
| 2010-12-31 | -$2.53M | n/m | 2014-03-28, From 2010-01-01 |
| 2009-12-31 | -$4.55M | n/m | 2014-03-28, From 2009-01-01 |
| 2008-12-31 | -$3.30M | n/m | 2014-03-28, From 2008-01-01 |
| 2007-12-31 | -$4.28M | n/m | 2014-03-28, From 2007-01-01 |
| 2006-12-31 | -$584.2K | n/m | 2014-03-28, From 2006-01-01 |
| 2005-12-31 | -$539.6K | n/m | 2014-03-28, From 2005-01-01 |
| 2004-12-31 | -$508.2K | n/m | 2014-03-28, From 2004-01-01 |
| 2003-12-31 | -$207.2K | n/m | 2014-03-28, From 2003-01-01 |
| 2002-12-31 | -$228.2K | n/m | 2014-03-28, From 2002-01-01 |
| 2001-12-31 | -$208.4K | n/m | 2014-03-28, From 2001-01-01 |
| 2000-12-31 | -$213.1K | n/m | 2014-03-28, From 2000-01-01 |
| 1999-12-31 | -$204.0K | n/a | 2014-03-28, From 1999-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Harrow, Inc. (HROW) | 2025-12-31 | -$5.14M | n/m |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | -$68.11M | n/m |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $124.45M | n/m |
| Arvinas, Inc. (ARVN) | 2025-12-31 | -$80.80M | n/m |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | -$103.27M | n/m |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $554.0K | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $24.02M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$51.64M | n/m |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | -$353.00M | n/m |
Compare HROW, VREOF, LGND, ARVN side by side · Screen every company in Pharmaceutical Preparations ↗